nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—breast cancer	0.281	1	CbGaD
Equilin—SHBG—Fluoxymesterone—breast cancer	0.247	1	CbGbCtD
Equilin—Estradiol—Fulvestrant—breast cancer	0.17	0.422	CrCrCtD
Equilin—Conjugated Estrogens—Exemestane—breast cancer	0.0847	0.211	CrCrCtD
Equilin—Estropipate—Exemestane—breast cancer	0.0847	0.211	CrCrCtD
Equilin—Estrone—Exemestane—breast cancer	0.0628	0.156	CrCrCtD
Equilin—HSD17B1—female reproductive system—breast cancer	0.00418	0.232	CbGeAlD
Equilin—HSD17B1—female gonad—breast cancer	0.00381	0.211	CbGeAlD
Equilin—HSD17B1—endocrine gland—breast cancer	0.00354	0.197	CbGeAlD
Equilin—SHBG—endometrium—breast cancer	0.000852	0.0473	CbGeAlD
Equilin—SHBG—uterus—breast cancer	0.000785	0.0436	CbGeAlD
Equilin—SHBG—pituitary gland—breast cancer	0.000771	0.0428	CbGeAlD
Equilin—SHBG—adipose tissue—breast cancer	0.000767	0.0426	CbGeAlD
Equilin—SHBG—female reproductive system—breast cancer	0.000705	0.0392	CbGeAlD
Equilin—SHBG—adrenal gland—breast cancer	0.000688	0.0382	CbGeAlD
Equilin—SHBG—bone marrow—breast cancer	0.000666	0.037	CbGeAlD
Equilin—SHBG—female gonad—breast cancer	0.000642	0.0356	CbGeAlD
Equilin—SHBG—endocrine gland—breast cancer	0.000597	0.0331	CbGeAlD
Equilin—Estradiol—GPER1—breast cancer	0.000514	0.129	CrCbGaD
Equilin—Estradiol—ESRRA—breast cancer	0.000331	0.0832	CrCbGaD
Equilin—Estriol—ESR2—breast cancer	0.000196	0.0492	CrCbGaD
Equilin—Estriol—SHBG—breast cancer	0.000179	0.0449	CrCbGaD
Equilin—Estropipate—ESR2—breast cancer	0.00015	0.0376	CrCbGaD
Equilin—Estropipate—SHBG—breast cancer	0.000137	0.0343	CrCbGaD
Equilin—Conjugated Estrogens—SLCO1B1—breast cancer	0.000135	0.0339	CrCbGaD
Equilin—Estrone—SLCO1B1—breast cancer	0.000135	0.0338	CrCbGaD
Equilin—Estriol—ESR1—breast cancer	0.000121	0.0303	CrCbGaD
Equilin—Conjugated Estrogens—ABCC1—breast cancer	0.000112	0.028	CrCbGaD
Equilin—Ethinyl Estradiol—ESR2—breast cancer	0.000107	0.0269	CrCbGaD
Equilin—Estradiol—SLCO1B1—breast cancer	0.000102	0.0256	CrCbGaD
Equilin—Conjugated Estrogens—COMT—breast cancer	0.0001	0.0252	CrCbGaD
Equilin—Ethinyl Estradiol—SHBG—breast cancer	9.76e-05	0.0245	CrCbGaD
Equilin—Conjugated Estrogens—ESR2—breast cancer	9.35e-05	0.0235	CrCbGaD
Equilin—Estrone—ESR2—breast cancer	9.32e-05	0.0234	CrCbGaD
Equilin—Estropipate—ESR1—breast cancer	9.23e-05	0.0232	CrCbGaD
Equilin—HSD17B1—Disease—SLC2A2—breast cancer	8.72e-05	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GLI2—breast cancer	8.63e-05	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VCP—breast cancer	8.63e-05	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTR—breast cancer	8.54e-05	0.00179	CbGpPWpGaD
Equilin—Estrone—CYP1B1—breast cancer	8.5e-05	0.0214	CrCbGaD
Equilin—Estrone—SHBG—breast cancer	8.5e-05	0.0214	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—LEPR—breast cancer	8.49e-05	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSPA1B—breast cancer	7.94e-05	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.93e-05	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ARHGDIA—breast cancer	7.89e-05	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MED12—breast cancer	7.7e-05	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—DPYD—breast cancer	7.7e-05	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FST—breast cancer	7.69e-05	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO1—breast cancer	7.61e-05	0.0016	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HEY2—breast cancer	7.6e-05	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDOA—breast cancer	7.58e-05	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RPS6KB2—breast cancer	7.51e-05	0.00157	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RGS2—breast cancer	7.42e-05	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA3—breast cancer	7.35e-05	0.00154	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL20—breast cancer	7.34e-05	0.00154	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A2—breast cancer	7.3e-05	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.23e-05	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF3—breast cancer	7.2e-05	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CPT1A—breast cancer	7.15e-05	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTR—breast cancer	7.15e-05	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG2—breast cancer	7.15e-05	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Disease—FASN—breast cancer	7.11e-05	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAG1—breast cancer	7.11e-05	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPAR1—breast cancer	7.11e-05	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TLE3—breast cancer	7.11e-05	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Disease—PARP1—breast cancer	7.08e-05	0.00148	CbGpPWpGaD
Equilin—Estradiol—ESR2—breast cancer	7.07e-05	0.0177	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—HEY1—breast cancer	7.04e-05	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HPGDS—breast cancer	7.02e-05	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALCA—breast cancer	6.99e-05	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HBA1—breast cancer	6.97e-05	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Disease—RPS6—breast cancer	6.91e-05	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DLL1—breast cancer	6.9e-05	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF4—breast cancer	6.86e-05	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Disease—CXCR4—breast cancer	6.83e-05	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—breast cancer	6.81e-05	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACHE—breast cancer	6.81e-05	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIST1H2BK—breast cancer	6.77e-05	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIST1H2BC—breast cancer	6.77e-05	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A1—breast cancer	6.75e-05	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE4D—breast cancer	6.71e-05	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRB7—breast cancer	6.71e-05	0.00141	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TAB2—breast cancer	6.6e-05	0.00138	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—breast cancer	6.59e-05	0.0166	CrCbGaD
Equilin—HSD17B1—Disease—TCF7L2—breast cancer	6.59e-05	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR2—breast cancer	6.54e-05	0.00137	CbGpPWpGaD
Equilin—Estradiol—SHBG—breast cancer	6.44e-05	0.0162	CrCbGaD
Equilin—Estradiol—CYP1B1—breast cancer	6.44e-05	0.0162	CrCbGaD
Equilin—HSD17B1—Metabolism—CYP17A1—breast cancer	6.44e-05	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DKK1—breast cancer	6.38e-05	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO1—breast cancer	6.38e-05	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS1—breast cancer	6.38e-05	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.35e-05	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSP90AA1—breast cancer	6.35e-05	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFC—breast cancer	6.33e-05	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.27e-05	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2D6—breast cancer	6.25e-05	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAG2—breast cancer	6.24e-05	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRL—breast cancer	6.18e-05	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—WNT1—breast cancer	6.15e-05	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA2—breast cancer	6.14e-05	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADAM10—breast cancer	6.09e-05	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FASN—breast cancer	5.95e-05	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—breast cancer	5.93e-05	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF10—breast cancer	5.92e-05	0.00124	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCG2—breast cancer	5.88e-05	0.0148	CrCbGaD
Equilin—Estrone—ABCG2—breast cancer	5.86e-05	0.0147	CrCbGaD
Equilin—HSD17B1—Metabolism—SLC5A5—breast cancer	5.86e-05	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH4—breast cancer	5.83e-05	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GZMB—breast cancer	5.79e-05	0.00121	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—breast cancer	5.76e-05	0.0145	CrCbGaD
Equilin—Estrone—ESR1—breast cancer	5.74e-05	0.0144	CrCbGaD
Equilin—HSD17B1—Disease—PDGFA—breast cancer	5.71e-05	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A1—breast cancer	5.66e-05	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NQO1—breast cancer	5.66e-05	0.00118	CbGpPWpGaD
Equilin—Estradiol—AR—breast cancer	5.65e-05	0.0142	CrCbGaD
Equilin—HSD17B1—Disease—TGFBR2—breast cancer	5.63e-05	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL2—breast cancer	5.62e-05	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGTR2—breast cancer	5.62e-05	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BMP2—breast cancer	5.56e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTHLH—breast cancer	5.56e-05	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Disease—ITPR1—breast cancer	5.54e-05	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.54e-05	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP3A4—breast cancer	5.52e-05	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB4—breast cancer	5.51e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT5A—breast cancer	5.51e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.49e-05	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1B1—breast cancer	5.42e-05	0.00114	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDNRB—breast cancer	5.39e-05	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGR—breast cancer	5.33e-05	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Disease—SMAD4—breast cancer	5.33e-05	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSP90AA1—breast cancer	5.32e-05	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—THBS1—breast cancer	5.31e-05	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—HES1—breast cancer	5.21e-05	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCOR1—breast cancer	5.18e-05	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA1—breast cancer	5.17e-05	0.00108	CbGpPWpGaD
Equilin—Estriol—ABCB1—breast cancer	5.13e-05	0.0129	CrCbGaD
Equilin—HSD17B1—Disease—FGF1—breast cancer	5.12e-05	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STK11—breast cancer	5.1e-05	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—breast cancer	5.1e-05	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRG1—breast cancer	5.08e-05	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FLT1—breast cancer	5.06e-05	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Disease—H2AFX—breast cancer	5.04e-05	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF3—breast cancer	5.04e-05	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SQSTM1—breast cancer	5.04e-05	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAG1—breast cancer	4.98e-05	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PARP1—breast cancer	4.96e-05	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH3—breast cancer	4.96e-05	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CALCA—breast cancer	4.9e-05	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERCC2—breast cancer	4.87e-05	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RPS6—breast cancer	4.84e-05	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF4—breast cancer	4.8e-05	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.79e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR4—breast cancer	4.78e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL12—breast cancer	4.78e-05	0.001	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB3—breast cancer	4.76e-05	0.000997	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR2—breast cancer	4.75e-05	0.000996	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COMT—breast cancer	4.74e-05	0.000993	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—breast cancer	4.72e-05	0.000988	CbGpPWpGaD
Equilin—Estropipate—CYP3A4—breast cancer	4.71e-05	0.0118	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PAK1—breast cancer	4.69e-05	0.000983	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—breast cancer	4.65e-05	0.000975	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ITPR1—breast cancer	4.64e-05	0.000972	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TCF7L2—breast cancer	4.61e-05	0.000966	CbGpPWpGaD
Equilin—Estrone—CYP1A1—breast cancer	4.59e-05	0.0115	CrCbGaD
Equilin—HSD17B1—Disease—MTHFR—breast cancer	4.57e-05	0.000958	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—breast cancer	4.56e-05	0.000956	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—breast cancer	4.47e-05	0.000935	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH2—breast cancer	4.45e-05	0.000931	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HSP90AA1—breast cancer	4.45e-05	0.000931	CbGpPWpGaD
Equilin—Estradiol—ABCG2—breast cancer	4.44e-05	0.0112	CrCbGaD
Equilin—HSD17B1—Disease—FGFR1—breast cancer	4.43e-05	0.000928	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TYMS—breast cancer	4.39e-05	0.000919	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—breast cancer	4.36e-05	0.000914	CbGpPWpGaD
Equilin—Estradiol—ESR1—breast cancer	4.35e-05	0.0109	CrCbGaD
Equilin—HSD17B1—Metabolism—GSTM1—breast cancer	4.33e-05	0.000908	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOR1—breast cancer	4.33e-05	0.000908	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G4A—breast cancer	4.33e-05	0.000908	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGTR1—breast cancer	4.33e-05	0.000906	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRL—breast cancer	4.33e-05	0.000906	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADAM10—breast cancer	4.26e-05	0.000893	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STK11—breast cancer	4.26e-05	0.000893	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—breast cancer	4.22e-05	0.000884	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLG—breast cancer	4.21e-05	0.000883	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX1—breast cancer	4.15e-05	0.00087	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF10—breast cancer	4.15e-05	0.000869	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A1—breast cancer	4.11e-05	0.000861	CbGpPWpGaD
Equilin—Estropipate—ALB—breast cancer	4.11e-05	0.0103	CrCbGaD
Equilin—HSD17B1—Metabolism—ERCC2—breast cancer	4.08e-05	0.000854	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFA—breast cancer	4e-05	0.000838	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—breast cancer	3.97e-05	0.000831	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFBR2—breast cancer	3.94e-05	0.000826	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOTCH1—breast cancer	3.93e-05	0.000823	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITPR1—breast cancer	3.88e-05	0.000813	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB4—breast cancer	3.86e-05	0.000808	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT5A—breast cancer	3.86e-05	0.000808	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP3—breast cancer	3.86e-05	0.000808	CbGpPWpGaD
Equilin—HSD17B1—Disease—KIT—breast cancer	3.84e-05	0.000805	CbGpPWpGaD
Equilin—HSD17B1—Disease—APC—breast cancer	3.84e-05	0.000805	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—breast cancer	3.83e-05	0.000803	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGF—breast cancer	3.8e-05	0.000796	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SMAD4—breast cancer	3.73e-05	0.000782	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1R—breast cancer	3.71e-05	0.000777	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HES1—breast cancer	3.65e-05	0.000764	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLA2G4A—breast cancer	3.62e-05	0.000759	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCOR1—breast cancer	3.62e-05	0.000759	CbGpPWpGaD
Equilin—HSD17B1—Disease—BRAF—breast cancer	3.61e-05	0.000757	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CSF2—breast cancer	3.58e-05	0.000751	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF1—breast cancer	3.58e-05	0.000751	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRG1—breast cancer	3.56e-05	0.000745	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—breast cancer	3.53e-05	0.00074	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—H2AFX—breast cancer	3.53e-05	0.00074	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT2—breast cancer	3.52e-05	0.000737	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—E2F1—breast cancer	3.51e-05	0.000735	CbGpPWpGaD
Equilin—Estradiol—CYP1A1—breast cancer	3.48e-05	0.00874	CrCbGaD
Equilin—HSD17B1—Disease—PIK3CD—breast cancer	3.38e-05	0.000708	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.38e-05	0.000707	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPP1—breast cancer	3.37e-05	0.000706	CbGpPWpGaD
Equilin—Ethinyl Estradiol—CYP3A4—breast cancer	3.36e-05	0.00845	CrCbGaD
Equilin—HSD17B1—Disease—SERPINE1—breast cancer	3.34e-05	0.0007	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB3—breast cancer	3.33e-05	0.000698	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR2—breast cancer	3.33e-05	0.000697	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—breast cancer	3.22e-05	0.000674	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—breast cancer	3.19e-05	0.000669	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—breast cancer	3.19e-05	0.000668	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR1—breast cancer	3.1e-05	0.00065	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—breast cancer	3.05e-05	0.00064	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—breast cancer	3.03e-05	0.000634	CbGpPWpGaD
Equilin—HSD17B1—Disease—RAF1—breast cancer	3.02e-05	0.000632	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—breast cancer	2.98e-05	0.000625	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—breast cancer	2.98e-05	0.000625	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—breast cancer	2.95e-05	0.000619	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—breast cancer	2.94e-05	0.000617	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTOR—breast cancer	2.94e-05	0.000617	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD4—breast cancer	2.94e-05	0.000616	CbGpPWpGaD
Equilin—Conjugated Estrogens—CYP3A4—breast cancer	2.94e-05	0.00738	CrCbGaD
Equilin—Estrone—CYP3A4—breast cancer	2.93e-05	0.00736	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—KDR—breast cancer	2.92e-05	0.000612	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—breast cancer	2.92e-05	0.000611	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—breast cancer	2.85e-05	0.000596	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—breast cancer	2.83e-05	0.000593	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FN1—breast cancer	2.81e-05	0.000589	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—breast cancer	2.8e-05	0.00703	CrCbGaD
Equilin—HSD17B1—Metabolism—ALB—breast cancer	2.79e-05	0.000585	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NFKBIA—breast cancer	2.78e-05	0.000582	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—breast cancer	2.76e-05	0.000579	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH1—breast cancer	2.75e-05	0.000577	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KIT—breast cancer	2.69e-05	0.000564	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—breast cancer	2.69e-05	0.000564	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—breast cancer	2.69e-05	0.000564	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—breast cancer	2.67e-05	0.00056	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGF—breast cancer	2.66e-05	0.000557	CbGpPWpGaD
Equilin—HSD17B1—Disease—CTNNB1—breast cancer	2.61e-05	0.000547	CbGpPWpGaD
Equilin—Estrone—ALB—breast cancer	2.56e-05	0.00642	CrCbGaD
Equilin—HSD17B1—Disease—CDKN1A—breast cancer	2.55e-05	0.000534	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—breast cancer	2.54e-05	0.000533	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BRAF—breast cancer	2.53e-05	0.00053	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—breast cancer	2.47e-05	0.000517	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—breast cancer	2.46e-05	0.000516	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT2—breast cancer	2.46e-05	0.000516	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—breast cancer	2.45e-05	0.00614	CrCbGaD
Equilin—HSD17B1—Metabolism—PTGS2—breast cancer	2.44e-05	0.000512	CbGpPWpGaD
Equilin—Estrone—ABCB1—breast cancer	2.44e-05	0.00613	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—breast cancer	2.37e-05	0.000496	CbGpPWpGaD
Equilin—HSD17B1—Disease—SRC—breast cancer	2.36e-05	0.000494	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—breast cancer	2.34e-05	0.00049	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—breast cancer	2.28e-05	0.000477	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—breast cancer	2.23e-05	0.000468	CbGpPWpGaD
Equilin—Estradiol—CYP3A4—breast cancer	2.22e-05	0.00558	CrCbGaD
Equilin—HSD17B1—Disease—MAPK3—breast cancer	2.17e-05	0.000456	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—breast cancer	2.13e-05	0.000446	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—breast cancer	2.12e-05	0.000444	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—breast cancer	2.11e-05	0.000443	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAF1—breast cancer	2.11e-05	0.000443	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—breast cancer	2.11e-05	0.000442	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RELA—breast cancer	2.1e-05	0.000441	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—breast cancer	2.09e-05	0.000438	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—breast cancer	2.07e-05	0.000433	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—breast cancer	2.06e-05	0.000432	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—breast cancer	2.06e-05	0.000432	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—breast cancer	1.98e-05	0.000415	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—breast cancer	1.95e-05	0.000409	CbGpPWpGaD
Equilin—Estradiol—ALB—breast cancer	1.94e-05	0.00487	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—breast cancer	1.94e-05	0.000405	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—breast cancer	1.9e-05	0.000397	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—breast cancer	1.89e-05	0.000397	CbGpPWpGaD
Equilin—Estradiol—ABCB1—breast cancer	1.85e-05	0.00464	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—breast cancer	1.85e-05	0.000387	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUN—breast cancer	1.84e-05	0.000386	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNB1—breast cancer	1.83e-05	0.000383	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—breast cancer	1.8e-05	0.000376	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—breast cancer	1.79e-05	0.000376	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1A—breast cancer	1.79e-05	0.000374	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—breast cancer	1.78e-05	0.000373	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK8—breast cancer	1.74e-05	0.000365	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—breast cancer	1.66e-05	0.000348	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SRC—breast cancer	1.65e-05	0.000346	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—breast cancer	1.61e-05	0.000337	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—breast cancer	1.59e-05	0.000334	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—breast cancer	1.59e-05	0.000333	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK3—breast cancer	1.52e-05	0.000319	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—breast cancer	1.5e-05	0.000315	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—breast cancer	1.48e-05	0.00031	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—breast cancer	1.48e-05	0.00031	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—breast cancer	1.47e-05	0.000307	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—breast cancer	1.45e-05	0.000303	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—breast cancer	1.37e-05	0.000287	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—breast cancer	1.26e-05	0.000263	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—breast cancer	1.23e-05	0.000257	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—breast cancer	1.22e-05	0.000255	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—breast cancer	1.16e-05	0.000244	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—breast cancer	1.11e-05	0.000233	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—breast cancer	1.03e-05	0.000215	CbGpPWpGaD
